FOLH1 and prostate cancer: Di-peptide, the dimerization of peptides (WQPDTAHHWATL) through the use of a lysine residue at the COOH terminus, was found to exhibit stronger specific affinity for prostate-specific membrane antigen (PSMA), which is highly expressed on the surface of prostate cancer cells [21].